InChI=1S/C20H34O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,12-13,15-19,21-23H,2-3,5-6,8-11,14H2,1H3,(H,24,25)/b7-4-,13-12+/t15-,16+,17+,18-,19+/m0/s1 |
PXGPLTODNUVGFL-YNNPMVKQSA-N |
CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\C=C/CCCC(O)=O |
|
Mus musculus
(NCBI:txid10090)
|
See:
MetaboLights Study
|
Mus musculus
(NCBI:txid10090)
|
Source: BioModels - MODEL1507180067
See:
PubMed
|
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
|
|
human metabolite
Any mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
mouse metabolite
Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
|
|
View more via ChEBI Ontology
(5Z,13E,15S)-9α,11α,15-trihydroxyprosta-5,13-dien-1-oic acid
|
dinoprost
|
ChemIDplus
|
dinoprosta
|
ChemIDplus
|
dinoprostum
|
ChemIDplus
|
(+)-Prostaglandin F2a
|
KEGG COMPOUND
|
(5Z,13E)-(15S)-9alpha,11alpha,15-Trihydroxyprosta-5,13-dienoate
|
KEGG COMPOUND
|
7-[3,5-Dihydroxy-2-(3-hydroxy-1-octenyl)cyclopentyl]-5-heptenoic acid
|
KEGG COMPOUND
|
9,11,15-Trihydroxy-(5Z,9a,11a,13E,15S)-prosta-5,13-dien-1-oic acid
|
KEGG COMPOUND
|
9a,11a-PGF2
|
KEGG COMPOUND
|
Amoglandin
|
KEGG COMPOUND
|
Cyclosin
|
KEGG COMPOUND
|
Dinoprost
|
KEGG COMPOUND
|
Enzaprost
|
KEGG COMPOUND
|
Enzaprost F
|
KEGG COMPOUND
|
l-PGF2-alpha
|
ChemIDplus
|
l-Prostaglandin F2-alpha
|
ChemIDplus
|
Panacelan
|
KEGG COMPOUND
|
PGF2a
|
KEGG COMPOUND
|
PGF2α
|
ChEBI
|
Prostaglandin F2a
|
KEGG COMPOUND
|
Prostaglandin F2alpha
|
KEGG COMPOUND
|
Prostin F 2 alpha
|
KEGG COMPOUND
|
Protamodin
|
KEGG COMPOUND
|
U 14583
|
KEGG COMPOUND
|
2225571
|
Reaxys Registry Number
|
Reaxys
|
2225571
|
Beilstein Registry Number
|
Beilstein
|
551-11-1
|
CAS Registry Number
|
KEGG COMPOUND
|
551-11-1
|
CAS Registry Number
|
ChemIDplus
|
11438482
|
PubMed citation
|
Europe PMC
|
23807981
|
PubMed citation
|
Europe PMC
|
|